Critical Care

official impact factor 4.60

Open Access Highly Access

Tirofiban preserves platelet loss during continuous renal replacement therapy in a randomised prospective open-blinded pilot study

Andreas Link*, Matthias Girndt, Simina Selejan, Ranja Rbah and Michael Böhm

Critical Care 2008, 12:R111 doi:10.1186/cc6998


See related commentary by Storm and Jörres, http://ccforum.com/content/12/6/193

Accesses  

  • Last 30 days: 42 accesses
  • Last 365 days: 562 accesses
  • All time: 3106 accesses